SBI Securities’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$144K Buy
3,366
+709
+27% +$38.5K ﹤0.01% 774
2026
Q1
$167K Sell
2,657
-1,398
-34% -$112K ﹤0.01% 689
2025
Q4
$387K Buy
4,055
+167
+4% +$16.4K 0.01% 447
2025
Q3
$380K Sell
3,888
-140
-3% -$14.5K 0.01% 454
2025
Q2
$433K Buy
4,028
+965
+32% +$97.6K 0.01% 398
2025
Q1
$309K Buy
3,063
+662
+28% +$66.7K 0.01% 430
2024
Q4
$214K Buy
+2,401
New +$211K 0.01% 522

Other funds holding BSX

SBI Securities's BSX Position: Q2 2026 in Review

SBI Securities increased its Boston Scientific (BSX) stake by 27% in Q2 2026, buying an estimated $38.5K and bringing the position to 3,366 shares worth $144K. The position accounts for ﹤0.01% of the portfolio, ranked #774.

SBI Securities first reported a position in BSX in Q4 2024 and has held it in 7 quarters since. The position peaked at $433K in Q2 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • SBI Securities held 3,366 shares of Boston Scientific worth $144K as of Q2 2026.
  • SBI Securities bought 709 Boston Scientific shares in Q2 2026, an estimated $38.5K.
  • Boston Scientific made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #774 holding.
  • SBI Securities first reported a position in Boston Scientific in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Boston Scientific position peaked at $433K in Q2 2025.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.